[Pretreatment dose of vecuronium and its effect on succinylcholine-induced fasciculations and neuromuscular blockade].
D000293:Adolescent; D000328:Adult; D000368:Aged; D005207:Fasciculation / Q000139:chemically induced / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009469:Neuromuscular Junction / Q000187:drug effects*; D010197:Pancuronium / Q000008:administration & dosage / Q000627:therapeutic use; D013390:Succinylcholine / Q000009:adverse effects*; D014403:Tubocurarine / Q000008:administration & dosage / Q000627:therapeutic use; D014673:Vecuronium Bromide / Q000008:administration & dosage* / Q000627:therapeutic use
D014673:Vecuronium Bromide; D013390:Succinylcholine; D010197:Pancuronium; D014403:Tubocurarine